Kalbe Farma Tbk PT (KLBF)

2,160
+60(+2.86%)
  • Volume:
    8,953,700
  • Bid/Ask:
    2,160/2,170
  • Day's Range:
    2,120 - 2,170
Earnings results expected in 3 days

Kalbe Farma will announce its quarterly financial results in 3 days. Traders should take this into account as the share price often fluctuates around this time period.

KLBF Overview

Prev. Close
2,100
Day's Range
2,120-2,170
Revenue
21.18T
Open
2,130
52 wk Range
1,530-2,360
EPS
72.55
Volume
8,953,700
Market Cap
99.91T
Dividend (Yield)
35.00
(1.56%)
Average Volume (3m)
25,370,557
P/E Ratio
29.77
Beta
0.319
1-Year Change
25.75%
Shares Outstanding
46,255,641,410
Next Earnings Date
30 Mar 2023
What is your sentiment on Kalbe Farma?
or
Vote to see community's results!

Kalbe Farma Tbk PT Company Profile

Kalbe Farma Tbk PT Company Profile

Employees
12501
Market
Indonesia

PT Kalbe Farma Tbk is an Indonesia-based pharmaceutical company. The Company’s business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over-the-counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments: infants, toddlers, children, pre-teenagers, teenagers, adults, pregnant and lactating women. It also offers a selection of non-milk nutritional products, such as Fitbar and Nutrive Benecol. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy